Pulse Biosciences Inc
6L8
Company Profile
Business description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Contact
601 Brickell Key Drive
Suite 1080
MiamiFL33131
USAT: +1 510 906-4600
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
75
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,820.30 | 6.40 | -0.07% |
CAC 40 | 7,829.29 | 72.96 | -0.92% |
DAX 40 | 24,255.31 | 201.50 | -0.82% |
Dow JONES (US) | 44,371.51 | 279.13 | -0.63% |
FTSE 100 | 8,941.12 | 34.54 | -0.38% |
HKSE | 24,139.57 | 111.20 | 0.46% |
NASDAQ | 20,585.53 | 45.14 | -0.22% |
Nikkei 225 | 39,569.68 | 76.68 | -0.19% |
NZX 50 Index | 12,686.68 | 73.52 | -0.58% |
S&P 500 | 6,259.75 | 20.71 | -0.33% |
S&P/ASX 200 | 8,580.10 | 9.10 | -0.11% |
SSE Composite Index | 3,510.18 | 0.50 | 0.01% |